MARS
发表于 2025-3-30 10:34:04
http://reply.papertrans.cn/67/6640/663982/663982_51.png
FIS
发表于 2025-3-30 15:29:57
http://reply.papertrans.cn/67/6640/663982/663982_52.png
Projection
发表于 2025-3-30 16:52:12
David Oliver,Sinead Maguire,Orla Hardiman,Peter Bede
听觉
发表于 2025-3-30 22:36:22
http://reply.papertrans.cn/67/6640/663982/663982_54.png
细胞
发表于 2025-3-31 01:27:38
Dementia and Cerebrovascular Disease, from dementia onset to death is 3.9 years for patients with VaD, as compared with 7.1 years for patients with AD. There are currently no established biochemical markers for VaD; and currently MR changes of ischaemia are the most widely used biomarker. Modifiable risk factors for VaD are those that
修饰
发表于 2025-3-31 08:57:06
http://reply.papertrans.cn/67/6640/663982/663982_56.png
Ballad
发表于 2025-3-31 09:45:01
Neuroinflammatory Disorders,, disease progression, and MS subtypes are being developed..As the disease progressses the majority of MS patients develop irreversible disability due to axonal loss. To date no DMT has been proven to alter the course of the progressive phase of the disease. However, recent advances in glial biology
混沌
发表于 2025-3-31 17:03:47
http://reply.papertrans.cn/67/6640/663982/663982_58.png
Lamina
发表于 2025-3-31 20:01:59
http://reply.papertrans.cn/67/6640/663982/663982_59.png